Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 2006
Certifications & Licensure
- FL State Medical License 2021 - Present
- TN State Medical License 2023 - 2027
- AZ State Medical License 2023 - 2026
- GA State Medical License 2023 - 2026
- MS State Medical License 2023 - 2026
- OK State Medical License 2020 - 2026
- TX State Medical License 2012 - 2026
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- Ixazomib and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma Start of enrollment: 2019 Aug 28
Roles: Contact, Principal Investigator
- Nivolumab, Ifosfamide, Carboplatin, and Etoposide as Second-Line Therapy in Treating Patients With Refractory or Relapsed HL Start of enrollment: 2017 Apr 24
Roles: Contact, Principal Investigator
- Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma Start of enrollment: 2018 Nov 28
Roles: Principal Investigator, Contact
- Join now to see all
Publications & Presentations
PubMed
- A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma.Neha Akkad, Lei Feng, Jason R Westin, Fredrick B Hagemeister, Hun Ju Lee
Blood Advances. 2025-09-09 - Brentuximab vedotin and nivolumab for untreated patients with Hodgkin lymphoma: long-term results.Bruce D Cheson, Nancy L Bartlett, Betsy Knopf, Hun J Lee, Ranjana H Advani
Blood Advances. 2025-08-12 - Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma.Charles Gaulin, Preetesh Jain, Ranjit Nair, Swaminathan P Iyer, Hun Ju Lee
Leukemia & Lymphoma. 2025-05-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: